Clinical Characteristics and Outcomes of Patients Hospitalized with COVID-19 at Case Hospital, Uganda

Table 4

Distribution of mortality across patient demographics, admission vitals and medications administered to patients with COVID-19 at case hospital.

Demographics	Died: n (%); N = 18	Alive: n (%); N = 142	-value
Age in years	58 (55–61)	42 (36–56)	0.001
Age categories
18–35	1 (3.3)	29 (96.7)	0.005
36–40	3 (4.6)	62 (95.4)
<18	14 (23)	47 (77)
≥50	0 (0)	4 (100)
Sex
Female	7 (12.1)	51 (87.9)	0.805
Male	11 (10.8)	91 (89.2)
Occupation
Formal	2 (20)	8 (80)	0.470
Informal	0 (0)	2 (100)
Unknown	16 (11)	130 (89)
Comorbidities
None	6 (6.5)	87 (93.5)	0.024
At least one	12 (17.9)	55 (82.1)
Hypertension
No	9 (7.7)	108 (92.3)	0.026
Yes	9 (20.9)	34 (79.1)
Diabetes mellitus
No	12 (9)	121 (91)	0.048
Yes	6 (22.2)	21 (77.8)
HIV
No	17 (10.8)	140 (89.2)	0.303
Yes	1 (33.3)	2 (66.7)
Others
No	16 (10.9)	131 (89.1)	0.643
Yes	2 (15.4)	11 (84.6)
Symptoms at admission
Asymptomatic	1 (33.3)	2 (66.7)	0.303
Symptomatic	17 (10.8)	140 (89.2)
Vitals at admission
Systolic blood pressure	131 (116–154)	131 (117–141)	0.772
Diastolic blood pressure	76 (64–82)	80 (73–90)	0.151
Heart rate	96 (83–124)	89 (80–102)	0.253
Respiratory rate	24 (20–36)	20 (20–22)	0.002
Temperature	36.4 (35.9–37.0)	36.4 (35.4–36.9)	0.852
Glasgow comma scale	15 (15–15)	15 (15–15)	>0.999
Random blood sugar	10.5 (4.7–16.3)	8.5 (5.8–14.1)	0.955
SpO2	87 (75–98)	95 (92–97)	0.031
≥92%	7 (6.0)	110 (94.0)	0.001
<92%	10 (24.4)	31 (75.6)
Medications
Azithromycin	14 (11.4)	109 (88.6)	>0.999
Dexamethasone	13 (10.8)	107 (89.2)	0.773
Vitamin C	14 (12.3)	100 (87.7)	0.593
Vitamin D	14 (12.3)	100 (87.7)	0.593
Enoxaparin	15 (13.3)	98 (86.7)	0.277
Zinc	12 (11.3)	94 (88.7)	0.968
Ulinastatin	11 (11.5)	85 (88.5)	0.919
Ivermectin	6 (33.3)	12 (66.7)	0.002
Remdesivir	4 (30.8)	9 (69.2)	0.042
Warfarin	0 (0)	1 (100)	>0.999